With 4 decades of dermatology advances, we asked the very dermatologist experts who we often contact to help us to report on the milestones to weigh in on what they think have made the most difference in theirs and their patients’ lives.
In this article, we highlight how sarecycline fits into the current treatment offerings for moderate-to-severe acne.
Acne patients are open to using effective antibiotic-free treatments if their prescriber offers them, says a recent study.
Over the past 40 years, there have been major dermatological breakthroughs that have changed the way doctors treat patients, along with the very treatments they use.
Today, the U.S. Food and Drug Administration approved the topical retinoid trifarotene 0.005% (AKLIEF, Galderma) for the treatment of acne vulgaris.
Niki Vora reflects on how her struggles with untreated atopic dermatitis, folliculitis and cystic acne led her to writing her scholarship-winning essay.
Are your patients happy with their current acne treatment? These five new therapeutic options could offer better results, according to several studies.
Refresh your memory on treatment guidelines for mild, moderate and severe acne in this easy-to-view slideshow.
Phase 3 studies suggest new topical retinoid effectively treats facial and truncal acne.
Cassiopea SpA submitted a New Drug Application (NDA) to the U.S. Federal Drug Administration (FDA) for its novel acne treatment, clascoterone cream 1%, according to a company announcement released today.